{"id": 229, "input_str": " BOSTON \u2014 The trajectory of amyloid plaque buildup\u2014clumps of abnormal proteins in the brain linked to Alzheimer\u2019s disease\u2014may serve as a more powerful biomarker for early detection of cognitive decline rather than using the total amount to gauge risk, researchers from Penn Medicine\u2019s Department of Radiology suggest in a new study published online July 15 in Neurobiology of Aging. An abstract (#O4-07-03) on the topic was also presented July 17 at the 2013", "correct_token_str": " Alzheimer", "generated_token_str": " annual", "generator_name": "text-ada-001", "correct_logprobs": [-5.346631, -3.1700082, -1.0097524], "generated_logprobs": [-1.7080095, -1.7409304, -2.6553307]}